A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

China Buys Robots from UVD Robots to Fight Coronavirus

Self-driving Danish disinfection robots are now shipping to a number of hospitals in China to help fight the coronavirus, also called COVID-19. This happened after Sunay Healthcare Supply today signed an agreement with the Danish company UVD Robots.

The first robots shipped this week and in the following weeks, many more robots will be shipped via air to be deployed in the fight against the coronavirus. With ultraviolet light, the Danish robot can disinfect and kill viruses and bacteria autonomously, effectively limiting the spread of coronaviruses without exposing hospital staff to the risk of infection.

Through Sunay Healthcare Supply’s partners in China, the robots will be deployed in all Chinese provinces. “With this agreement, more than 2,000 hospitals will now have the opportunity to ensure effective disinfection, protecting both their patients and staff,” says Su Yan, CEO of Sunay Healthcare Supply, a medical equipment supplier to the Chinese market.

Now sold in more than 40 countries, UVD Robots is already delivering its self-driving disinfection robots to hospitals in other parts of Asia in addition to healthcare markets in Europe and the United States. The invention increases the safety of both staff, patients and their relatives by reducing the risk of contact with bacteria, viruses and other harmful microorganisms. The concentrated UV-C light emitted by the robots as they drive has a germicidal effect that removes virtually all airborne viruses and bacteria on the surfaces of a room. Results, that led to the UVD robot winning the robotics industry’s “Oscar” – IERA Award in 2019.


Before entering into the agreement with UVD Robots, Sunay Healthcare Supply did its due diligence and screened the market for the best technologies to fight the coronavirus.

“We found the UVD robot to be superior compared to other technologies and are pleased to – in a very short amount of time – enter into a reseller agreement with exclusive rights to supply the UVD robots in China,” says Su Yan, emphasizing how both parties have worked intensively to get deliveries of robots to the Chinese hospitals.

CEO of UVD Robots, Per Juul Nielsen, is pleased to be helping combat the spread of the virus in China through the company’s solution: “In a severe crisis like this where the world health is threatened, our innovative technology really proves its worth,” he says.

UVD Robots is a portfolio company in Blue Ocean Robotics, which develops a wide range of service robots.

The development of the UVD robot started in 2014, when a group of Danish hospitals demanded a far more effective way of reducing infection rates in hospitals. The fruitful collaboration between bacteriologists, virologists and hospital staff from hospitals, and robot developers, designers, engineers, investors and business people from Blue Ocean Robotics led to an early market introduction in 2018.

Claus Risager, CEO of Blue Ocean Robotics and Chairman of the Board of UVD Robots, calls it a tremendous satisfaction for employees, management and the circle of owners to witness the deployment of the UVD Robot. “We are now helping solve one of the biggest problems of our time, preventing the spread of bacteria and viruses with a robot that saves lives in hospitals every day.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy